Jaroslav Kynčl

Potential Treatment of Alzheimer Disease Using Cholinergic Channel Activators (ChCAs) with Cognitive Enhancement, Anxiolytic-like, and Cytoprotective Properties

Stephen P. Arnerić, James P. Sullivan, Michael Decker et al. · Alzheimer Disease & Associated Disorders · 1995 · 43 citations

Medicine, Neuroscience, Pharmacology +17

Antihypertensive action of indapamide and review of pharmacology and toxicology

Roger A. Moore, Takashi Seki, Shozo Ohsumi et al. · Current Medical Research and Opinion · 1977 · 40 citations

Medicine, Pharmacology, Cardiovascular Pharmacotherapy +14

Preclinical Pharmacology of ABT‐418: A Prototypical Cholinergic Channel Activator for the Potential Treatment of Alzheimer's Disease

Stephen P. Arnerić, David J. Anderson, Anthony W. Bannon et al. · CNS Drug Reviews · 1995 · 40 citations

Medicine, Neuroscience, Pharmacology +16

Drugs derived from cannabinoids. 2. Basic esters of nitrogen and carbocyclic analogs

Raj K. Razdan, B. Zitko Terris, Harry G. Pars et al. · Journal of Medicinal Chemistry · 1976 · 34 citations

Medicine, Medicinal Chemistry, Pharmacology +6

Increased fluid turnover and the activity of the renin-angiotensin system under various experimental conditions.

G Dauda, S Kazdo, Jaroslav Kynčl et al. · PubMed · 1972 · 32 citations

Life Sciences, Endocrinology, Physiology +11